Immunohistochemical localization of PDE10A in the rat brain
- PMID: 12967715
- DOI: 10.1016/s0006-8993(03)02754-9
Immunohistochemical localization of PDE10A in the rat brain
Abstract
PDE10A is a newly identified cAMP/cGMP phosphodiesterase for which mRNA is highly expressed in the mammalian striatum. In the present study, PDE10A protein and mRNA expression throughout the rat brain were determined, using a monoclonal antibody (24F3.F11) for Western blot and immunohistochemical analyses and an antisense riboprobe for in situ hybridization. High levels of mRNA are observed in most of the neuronal cell bodies of striatal complex (caudate n, n. accumbens and olfactory tubercle), indicating that PDE10A is expressed by the striatal medium spiny neurons. PDE10A-like immunoreactivity is dense throughout the striatal neuropil, as well as in the internal capsule, globus pallidus, and substantia nigra. These latter regions lack significant expression of PDE10A mRNA. Thus, PDE10A is transported throughout the dendritic tree and down the axons to the terminals of the medium spiny neurons. These data suggest a role for PDE10A in regulating activity within both the striatonigral and striatopallidal pathways. In addition, PDE10A immunoreactivity and mRNA are found at lower levels in the hippocampal pyramidal cell layer, dentate granule cell layer and throughout the cortex and cerebellar granule cell layer. Immunoreactivity is detected only in cell bodies in these latter regions. This more restricted subcellular localization of PDE10A outside the striatum suggests a second, distinct function for the enzyme in these regions.
Similar articles
-
Phosphodiesterase-10A Inverse Changes in Striatopallidal and Striatoentopeduncular Pathways of a Transgenic Mouse Model of DYT1 Dystonia.J Neurosci. 2017 Feb 22;37(8):2112-2124. doi: 10.1523/JNEUROSCI.3207-15.2016. Epub 2017 Jan 23. J Neurosci. 2017. PMID: 28115486 Free PMC article.
-
Immunohistochemical localization of phosphodiesterase 10A in multiple mammalian species.J Histochem Cytochem. 2006 Nov;54(11):1205-13. doi: 10.1369/jhc.6A6930.2006. Epub 2006 Jul 24. J Histochem Cytochem. 2006. PMID: 16864896
-
PDE10A and PDE10A-dependent cAMP catabolism are dysregulated oppositely in striatum and nucleus accumbens after lesion of midbrain dopamine neurons in rat: a key step in parkinsonism physiopathology.Neurobiol Dis. 2011 Jul;43(1):293-303. doi: 10.1016/j.nbd.2011.04.006. Epub 2011 Apr 16. Neurobiol Dis. 2011. PMID: 21515371
-
Current Understanding of PDE10A in the Modulation of Basal Ganglia Circuitry.Adv Neurobiol. 2017;17:15-43. doi: 10.1007/978-3-319-58811-7_2. Adv Neurobiol. 2017. PMID: 28956328 Review.
-
PDE10A mutations help to unwrap the neurobiology of hyperkinetic disorders.Cell Signal. 2019 Aug;60:31-38. doi: 10.1016/j.cellsig.2019.04.001. Epub 2019 Apr 2. Cell Signal. 2019. PMID: 30951862 Review.
Cited by
-
A phase 1 study of the safety, tolerability, pharmacokinetics, and pharmacodynamics of TAK-063, a selective PDE10A inhibitor.Psychopharmacology (Berl). 2016 Oct;233(21-22):3787-3795. doi: 10.1007/s00213-016-4412-9. Epub 2016 Aug 30. Psychopharmacology (Berl). 2016. PMID: 27572830 Free PMC article. Clinical Trial.
-
Characterization of [11C]Lu AE92686 as a PET radioligand for phosphodiesterase 10A in the nonhuman primate brain.Eur J Nucl Med Mol Imaging. 2017 Feb;44(2):308-320. doi: 10.1007/s00259-016-3544-9. Epub 2016 Nov 5. Eur J Nucl Med Mol Imaging. 2017. PMID: 27817159 Free PMC article.
-
Radiosynthesis and Radiotracer Properties of a 7-(2-[18F]Fluoroethoxy)-6-methoxypyrrolidinylquinazoline for Imaging of Phosphodiesterase 10A with PET.Pharmaceuticals (Basel). 2012 Feb 6;5(2):169-88. doi: 10.3390/ph5020169. Pharmaceuticals (Basel). 2012. PMID: 24288087 Free PMC article.
-
Challenges on Cyclic Nucleotide Phosphodiesterases Imaging with Positron Emission Tomography: Novel Radioligands and (Pre-)Clinical Insights since 2016.Int J Mol Sci. 2021 Apr 7;22(8):3832. doi: 10.3390/ijms22083832. Int J Mol Sci. 2021. PMID: 33917199 Free PMC article. Review.
-
Analysis of striatal transcriptome in mice overexpressing human wild-type alpha-synuclein supports synaptic dysfunction and suggests mechanisms of neuroprotection for striatal neurons.Mol Neurodegener. 2011 Dec 13;6:83. doi: 10.1186/1750-1326-6-83. Mol Neurodegener. 2011. PMID: 22165993 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous